INBX logo

Inhibrx Biosciences, Inc. (INBX) Cash From Investing

Annual CFI:

-$2.60M+$2.00M(+43.46%)
December 31, 2024

Summary

  • As of today, INBX annual cash from investing is -$2.60 million, with the most recent change of +$2.00 million (+43.46%) on December 31, 2024.
  • During the last 3 years, INBX annual cash from investing has fallen by -$1.79 million (-221.01%).
  • INBX annual cash from investing is now -278.57% below its all-time high of -$686.00 thousand, reached on December 31, 2022.

Performance

1-Year Change

+43.46%

3-Year Change

-221.01%

5-Year Change

-43.48%

15-Year Change

-93.81%

INBX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

39.95%
INBX annual cash from investing is higher than 39.95% of companies in Healthcare sector

Range

All-Time High

-$686.00K
INBX annual cash from investing is currently -278.57% below its historical high of -$686.00 thousand

3-Year Low

-$4.59M
INBX annual cash from investing is currently +43.46% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
INBX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 31, 2026
INBX next annual earnings announcement is scheduled for Mar 31, 2026

OtherINBXcash flow metrics

Annual CFF

$71.68M
INBX annual cash from financing is $71.68 million

Annual CFO

-$194.41M
INBX annual cash from operations is -$194.41 million

Annual FCF

-$197.01M
INBX annual free cash flow is -$197.01 million

Annual CAPEX

$2.60M
INBX annual capital expenditures is $2.60 million

Quarterly CFI:

-$7000.00-$7000.00(-100.00%)
September 30, 2025

Summary

  • As of today, INBX quarterly cash from investing is -$7000.00, with the most recent change of -$7000.00 (-100.00%) on September 30, 2025.
  • Over the past year, INBX quarterly cash from investing has increased by +$240.00 thousand (+97.17%).
  • INBX quarterly cash from investing is now -135.00% below its all-time high of $20.00 thousand, reached on September 30, 2022.

Performance

3-Month Change

-100%

1-Year Change

+97.17%

3-Year Change

-135%

5-Year Change

+97.66%

INBX Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

50.85%
INBX quarterly cash from investing is higher than 50.85% of companies in Healthcare sector

Range

All-Time High

$20.00K
INBX quarterly cash from investing is currently -135.00% below its historical high of $20.00 thousand

3-Year Low

-$1.22M
INBX quarterly cash from investing is currently +99.42% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
INBX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 31, 2026
INBX next earnings announcement is scheduled for Mar 31, 2026

OtherINBXcash flow metrics

Quarterly CFF

$352.00K
INBX quarterly cash from financing is $352.00 thousand

Quarterly CFO

-$33.82M
INBX quarterly cash from operations is -$33.82 million

Quarterly FCF

-$33.83M
INBX quarterly free cash flow is -$33.83 million

Quarterly CAPEX

$10.00K
INBX quarterly capital expenditures is $10.00 thousand

TTM CFI:

-$44.00K+$240.00K(+84.51%)
September 30, 2025

Summary

  • As of today, INBX TTM cash from investing is -$44.00 thousand, with the most recent change of +$240.00 thousand (+84.51%) on September 30, 2025.
  • Over the past year, INBX TTM cash from investing has increased by +$2.54 million (+98.30%).
  • INBX TTM cash from investing is now at all-time high.

Performance

3-Month Change

+84.51%

1-Year Change

+98.3%

3-Year Change

+93.59%

5-Year Change

+95.95%

INBX TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

55.23%
INBX TTM cash from investing is higher than 55.23% of companies in Healthcare sector

Range

All-Time High

-$44.00K
INBX TTM cash from investing is currently at an all-time high

3-Year Low

-$2.60M
INBX TTM cash from investing is currently +98.31% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
INBX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 31, 2026
INBX next earnings announcement is scheduled for Mar 31, 2026

OtherINBXcash flow metrics

TTM CFF

$100.19M
INBX TTM cash from financing is $100.19 million

TTM CFO

-$143.39M
INBX TTM cash from operations is -$143.39 million

TTM FCF

-$143.44M
INBX TTM free cash flow is -$143.44 million

TTM CAPEX

$47.00K
INBX TTM capital expenditures is $47.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

INBX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+43.5%+97.2%+98.3%
3Y3 Years-221.0%-135.0%+93.6%
5Y5 Years-43.5%+97.7%+96.0%

INBX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-278.6%+43.5%-135.0%+99.4%at high+98.3%
5Y5-Year-278.6%+43.5%-135.0%+99.4%at high+98.3%
All-TimeAll-Time-278.6%+43.5%-135.0%+99.4%at high+98.3%

INBX Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$7000.00(>-9900.0%)
-$44.00K(+84.5%)
Jun 2025
-
$0.00(+100.0%)
-$284.00K(+81.1%)
Mar 2025
-
-$21.00K(-31.3%)
-$1.50M(+42.3%)
Dec 2024
-$2.60M(+43.5%)
-$16.00K(+93.5%)
-$2.60M(-0.6%)
Sep 2024
-
-$247.00K(+79.7%)
-$2.58M(-10.6%)
Jun 2024
-
-$1.22M(-8.6%)
-$2.33M(-62.5%)
Mar 2024
-
-$1.12M(-253.0%)
-$1.44M(-144.6%)
Dec 2023
-$4.59M(-569.5%)
-
-
Jun 2023
-
-$317.00K(-1278.3%)
-$587.00K(+0.8%)
Mar 2023
-
-$23.00K(+91.4%)
-$592.00K(+13.7%)
Dec 2022
-$686.00K(+15.2%)
-$267.00K(-1435.0%)
-$686.00K(0.0%)
Sep 2022
-
$20.00K(+106.2%)
-$686.00K(+21.6%)
Jun 2022
-
-$322.00K(-175.2%)
-$875.00K(+4.1%)
Mar 2022
-
-$117.00K(+56.2%)
-$912.00K(-12.7%)
Dec 2021
-$809.00K
-$267.00K(-58.0%)
-$809.00K(+29.9%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$169.00K(+52.9%)
-$1.15M(+10.1%)
Jun 2021
-
-$359.00K(-2464.3%)
-$1.28M(+0.2%)
Mar 2021
-
-$14.00K(+97.7%)
-$1.29M(+5.6%)
Dec 2020
-$1.36M(+24.6%)
-$612.00K(-104.7%)
-$1.36M(-25.5%)
Sep 2020
-
-$299.00K(+17.4%)
-$1.09M(+27.5%)
Jun 2020
-
-$362.00K(-297.8%)
-$1.50M(+17.8%)
Mar 2020
-
-$91.00K(+72.8%)
-$1.82M(-0.8%)
Dec 2019
-$1.81M(-26.7%)
-$335.00K(+52.9%)
-$1.81M(-22.7%)
Sep 2019
-
-$711.00K(-3.5%)
-$1.48M(-93.1%)
Jun 2019
-
-$687.00K(-792.2%)
-$764.00K(-29.9%)
Mar 2019
-
-$77.00K(+84.9%)
-$588.00K(-0.3%)
Dec 2018
-$1.43M(-6.6%)
-
-
Jun 2018
-
-$511.00K(-581.3%)
-$586.00K(-681.3%)
Mar 2018
-
-$75.00K
-$75.00K
Dec 2017
-$1.34M
-
-

FAQ

  • What is Inhibrx Biosciences, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Inhibrx Biosciences, Inc.?
  • What is Inhibrx Biosciences, Inc. annual cash from investing year-on-year change?
  • What is Inhibrx Biosciences, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Inhibrx Biosciences, Inc.?
  • What is Inhibrx Biosciences, Inc. quarterly cash from investing year-on-year change?
  • What is Inhibrx Biosciences, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Inhibrx Biosciences, Inc.?
  • What is Inhibrx Biosciences, Inc. TTM cash from investing year-on-year change?

What is Inhibrx Biosciences, Inc. annual cash from investing?

The current annual cash from investing of INBX is -$2.60M

What is the all-time high annual cash from investing for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high annual cash from investing is -$686.00K

What is Inhibrx Biosciences, Inc. annual cash from investing year-on-year change?

Over the past year, INBX annual cash from investing has changed by +$2.00M (+43.46%)

What is Inhibrx Biosciences, Inc. quarterly cash from investing?

The current quarterly cash from investing of INBX is -$7000.00

What is the all-time high quarterly cash from investing for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high quarterly cash from investing is $20.00K

What is Inhibrx Biosciences, Inc. quarterly cash from investing year-on-year change?

Over the past year, INBX quarterly cash from investing has changed by +$240.00K (+97.17%)

What is Inhibrx Biosciences, Inc. TTM cash from investing?

The current TTM cash from investing of INBX is -$44.00K

What is the all-time high TTM cash from investing for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high TTM cash from investing is -$44.00K

What is Inhibrx Biosciences, Inc. TTM cash from investing year-on-year change?

Over the past year, INBX TTM cash from investing has changed by +$2.54M (+98.30%)
On this page